Literature DB >> 4061126

Effect of quinine on plasma digoxin concentration and renal digoxin clearance.

K E Pedersen, J Lysgaard Madsen, N A Klitgaard, K Kjaer, S Hvidt.   

Abstract

In order to explore the digoxin-quinine interaction, digoxin steady state pharmacokinetics was studied before and during quinine coadministration in seven healthy subjects. Quinine (250 mg/day) increased mean plasma digoxin concentration from 0.64 +/- 0.12 to 0.80 +/- 0.18 ng/ml (p less than 0.05) within one week. Urinary digoxin recovery rose from 154.0 +/- 18.8 to 181.5 +/- 22.6 micrograms/24 h (p less than 0.01), whereas renal digoxin clearance was unaltered in the presence of quinine (181.5 +/- 24.2 vs. 174.1 +/- 26.5 ml/min). An increase in quinine dose (to 750 mg/day) caused further increments in plasma digoxin levels, whereas renal digoxin clearance remained unchanged. Quinine elevates plasma digoxin concentrations in a stepwise fashion probably due to an impairment of extrarenal digoxin clearance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4061126     DOI: 10.1111/j.0954-6820.1985.tb08852.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  5 in total

1.  The effect of meloxicam on the pharmacokinetics of beta-acetyl-digoxin.

Authors:  F L Degner; G Heinzel; H Narjes; D Türck
Journal:  Br J Clin Pharmacol       Date:  1995-11       Impact factor: 4.335

Review 2.  Clinical pharmacokinetic significance of the renal tubular secretion of digoxin.

Authors:  G Koren
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

Review 3.  Adverse effects of antimalarials. An update.

Authors:  G A Luzzi; T E Peto
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

Review 4.  Pharmacokinetic drug interactions with antimicrobial agents.

Authors:  J G Gillum; D S Israel; R E Polk
Journal:  Clin Pharmacokinet       Date:  1993-12       Impact factor: 6.447

5.  Interventions for leg cramps in pregnancy.

Authors:  Li Luo; Kunyan Zhou; Jing Zhang; Liangzhi Xu; Weiyao Yin
Journal:  Cochrane Database Syst Rev       Date:  2020-12-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.